Pandemiastatus tarkistus 21.3.2022 Tieteellisiä artikkeleita

 B.1.1.529 omikronia  koskevia artikkeleita 10 ( kaikkiaan  287 saatavilla)

B.1.1.529 Publications & Resources

287 results

Publication

Monoclonal antibody and antiviral therapy for treatment of mild-to-moderate COVID-19 in pediatric patients Surabhi B Vora et al.medRxiv18 March 2022

Publication

Suppression of de novo antibody responses against SARS-CoV2 and the Omicron variant after mRNA vaccination and booster in patients with B cell malignancies undergoing active treatment, but maintenance of pre-existing antibody levels against endemic viruses. Joseph Azar et al.medRxiv18 March 2022

Publication

From Delta to Omicron SARS-CoV-2 variant: switch to saliva sampling for higher detection rate Margot Cornette et al.medRxiv18 March 2022

Publication

A multiplexed Cas13-based assay with point-of-care attributes for simultaneous COVID-19 diagnosis and variant surveillance Maturada Patchsung et al.medRxiv18 March 2022

Publication

Potent and specific human monoclonal antibodies against SARS-CoV-2 Omicron variant by rapid mRNA immunization of humanized mice Ping Ren et al.bioRxiv18 March 2022

Publication

Broad neutralization of SARS-CoV-2 variants by circular mRNA producing VFLIP-X spike in mice Chotiwat Seephetdee et al.bioRxiv17 March 2022

Publication

Structural basis of Omicron immune evasion: A comparative computational study of Spike protein-Antibody interaction. Darshan Contractor et al.bioRxiv15 March 2022

Publication

Pulmonary lesions following inoculation with the SARS-CoV-2 Omicron BA.1 (B.1.1.529) variant in Syrian golden hamsters Melanie Rissmann et al.bioRxiv15 March 2022

Publication

A broad and potent neutralization epitope in SARS-related coronaviruses Meng Yuan et al.bioRxiv14 March 2022

Publication

Development of a ferritin-based nanoparticle vaccine against the SARS-CoV-2 Omicron variant Wanbo Tai et al.bioRxiv14 March 2022